PCT

Procalcitonin

Immune & Inflammation

What is Procalcitonin?

Procalcitonin (PCT) is a 116-amino acid precursor peptide of the hormone calcitonin. Under normal conditions, procalcitonin is produced exclusively by the C-cells of the thyroid gland and is rapidly cleaved to calcitonin before being released into the blood, resulting in very low circulating procalcitonin levels (<0.05 ng/mL). However, during systemic bacterial infections and sepsis, virtually every tissue in the body can produce procalcitonin in response to bacterial endotoxins and pro-inflammatory cytokines (particularly IL-6, TNF-α, and IL-1β). This extrathyroidal production causes dramatic elevations in serum procalcitonin.

Procalcitonin has emerged as one of the most useful biomarkers for distinguishing bacterial from viral infections and for guiding antibiotic therapy. Unlike CRP and ESR, which rise in response to any inflammatory stimulus, procalcitonin rises specifically in response to bacterial infection and is typically not elevated (or only minimally elevated) in viral infections, autoimmune inflammation, or allergic reactions. Procalcitonin rises within 2–4 hours of bacterial infection onset (faster than CRP), peaks at 24 hours, and has a half-life of approximately 24 hours, allowing it to track response to antibiotic therapy in near real-time.

Why It Matters

Procalcitonin helps clinicians make critical antibiotic decisions: whether to start antibiotics, and when to safely stop them. Antibiotic overuse drives antimicrobial resistance—one of the greatest threats to global health. Randomized controlled trials have demonstrated that procalcitonin-guided antibiotic stewardship in lower respiratory tract infections and sepsis reduces antibiotic exposure by 2–3 days without increasing mortality. In the ICU, procalcitonin helps differentiate sepsis from non-infectious causes of systemic inflammation (SIRS), guiding appropriate therapy and avoiding unnecessary antibiotics.

Normal Reference Ranges

GroupRangeUnit
Healthy Adults<0.05ng/mL
Possible Bacterial Infection0.1–0.25ng/mL
Likely Bacterial Infection0.25–0.5ng/mL
Severe Bacterial Infection/Sepsis>0.5ng/mL
Septic Shock>10ng/mL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High PCT Levels Mean

Common Causes

  • Bacterial sepsis and severe bacterial infections
  • Bacterial pneumonia
  • Bacterial meningitis
  • Urinary tract infections (pyelonephritis)
  • Intra-abdominal infections (peritonitis, abscess)
  • Major surgery or trauma (transient elevation)
  • Medullary thyroid carcinoma
  • Severe burns

Possible Symptoms

  • Fever and chills
  • Rapid heart rate and low blood pressure (in sepsis)
  • Altered mental status
  • Rapid breathing
  • Productive cough (in pneumonia)
  • Abdominal pain (in intra-abdominal infection)
  • Symptoms specific to the infection site

What to do: Interpret procalcitonin in clinical context: PCT >0.5 ng/mL strongly supports bacterial infection—initiate appropriate empiric antibiotics after obtaining cultures. PCT >2 ng/mL indicates high risk of severe sepsis and organ dysfunction—follow sepsis bundles (cultures, antibiotics within 1 hour, IV fluids, lactate monitoring). Monitor PCT every 24–48 hours to track treatment response. A decline of >80% from peak or an absolute value <0.5 ng/mL supports antibiotic discontinuation. In post-surgical patients, mild elevation (0.5–2 ng/mL) may be non-infectious and transient.

What Low PCT Levels Mean

Common Causes

  • No bacterial infection (normal finding)
  • Viral infection (characteristically low)
  • Autoimmune inflammation without infection
  • Localized infection without systemic involvement
  • Early bacterial infection (first 2–4 hours)

Possible Symptoms

  • No symptoms from low procalcitonin itself

What to do: Low procalcitonin (<0.25 ng/mL) in a patient with suspected infection suggests viral rather than bacterial etiology—antibiotics can generally be withheld with close follow-up. This is particularly useful in lower respiratory tract infections, where viral and bacterial etiologies present similarly. However, a low procalcitonin does not absolutely exclude bacterial infection in localized infections, early infection (<6 hours), or immunocompromised patients. Clinical judgment should always accompany biomarker-guided decisions.

When Is PCT Testing Recommended?

  • When differentiating bacterial from viral lower respiratory tract infection
  • When sepsis is suspected in the ICU or emergency department
  • When guiding antibiotic duration in hospitalized patients
  • When evaluating fever of unknown origin
  • When assessing response to antibiotic therapy in serious infections

Frequently Asked Questions

Procalcitonin-guided antibiotic stewardship has been validated in numerous randomized controlled trials, most notably the ProACT trial and the PRORATA trial. The approach works on two levels: initiation (withholding antibiotics when PCT <0.25 ng/mL in lower respiratory infections, suggesting viral etiology) and discontinuation (stopping antibiotics when PCT drops by >80% from peak or falls below 0.25–0.5 ng/mL). The landmark meta-analysis by Schuetz et al. (2018) involving over 6,700 patients showed that PCT-guided therapy reduced antibiotic exposure by 2.4 days and antibiotic-related side effects by 16%, with no increase in mortality or treatment failure. The FDA approved procalcitonin for guiding antibiotic decisions in lower respiratory tract infections in 2017.
The mechanism relates to the cytokine environment of different infections. Bacterial infections trigger the release of IL-6, TNF-α, and IL-1β, which stimulate extrathyroidal procalcitonin production in tissues throughout the body—liver, kidney, lung, adipose tissue, and others all express the CALC-1 gene in response to bacterial signals. Viral infections, in contrast, induce interferon-γ (IFN-γ), which actively suppresses procalcitonin production. This creates a "bacterial = high PCT, viral = low PCT" pattern that is remarkably consistent. There are exceptions: some viral infections with secondary bacterial superinfection will raise PCT, and certain severe viral infections (particularly influenza with ARDS) can cause modest elevation. The clinical cutoff of 0.25 ng/mL accounts for this overlap.
Yes. Non-infectious causes of elevated procalcitonin include: major surgery and trauma (PCT typically rises in the first 24–48 hours post-operatively and declines by day 3–5 without infection), severe burns, medullary thyroid carcinoma (constitutive PCT production by C-cells), small cell lung cancer, carcinoid tumors, massive blood transfusions, prolonged cardiac arrest or shock, and certain medications (OKT3, anti-thymocyte globulin). Neonates have physiologically elevated PCT in the first 48 hours of life. In these contexts, the trend of PCT (rising vs. falling) and the absolute level help distinguish infection from non-infectious elevation—persistently rising or very high PCT (>10 ng/mL) strongly favors bacterial infection, while post-surgical elevation typically peaks early and declines.

Related Biomarkers

CRPC-Reactive ProteinWBCWhite Blood CellsESRErythrocyte Sedimentation Rate

Want your PCT levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.